Synthesis and Biological Activity of Functionally Substituted Pyrimidine and Pyran Derivatives on the Basis of Isatylidene Malononitriles

dc.contributor.authorNaghiyev, Farid
dc.contributor.authorMamedov, Ibrahim
dc.contributor.authorAskerov, Rizvan
dc.contributor.authorTaslimi, Parham
dc.contributor.authorPoustforoosh, Alireza
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2025-10-18T09:58:45Z
dc.date.created2022
dc.date.issued2022
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractIn this study, it was shown that pyrimidine and imidazopyridine derivatives were obtained from the multicomponent reaction of isatylidene malononitriles with malononitrile and diamines at room temperature. Also, the interaction of 2-(5-bromo-2-oxoindoline-3-ylidene)with malononitrile and benzoyl acetone (or ethyl-4-chlorine-acetoacetate) was carried out and the formation of the corresponding pyran derivatives was observed.The structure of the synthesized compounds was confirmed by H-1, (CNMR)-C-13 spectroscopy and X-ray analysis. The acetylcholinesterase (AChE) inhibitor compounds recorded as important therapeutic drugs for the therapy of Alzheimer's disease. Also, novel complexes effectively inhibited AChE enzyme, with Ki values in the range of 4.56 to 8.21 mu M. For this enzyme, it was obtained with IC50 values in the range of 4.04 to 9.85 mu M. For alpha-glycosidase enzyme the most effective Ki values were for 4 a and 10 compounds with Ki values of 31.48 and 32.63 mu M, respectively. The molecular docking study was employedto investigate of chemical activities and interaction of synthesized compounds with low Ki in the presence of AChE, butyrylcholinesterase, and alpha-Glycosidase. The results revealed that some of the compounds, like compound 9 have a good binding affinity to AChE with a docking score of -6.243 (kcal/mol). This compound can affect the enzyme activity by attachment to essential residues of the catalytic domain of the enzyme. The ADME/T analysis was also performed and revealed that compounds have the potential to be utilized as medicine.
dc.identifier.doi10.1002/slct.202202006
dc.identifier.issn2365-6549
dc.identifier.issue33
dc.identifier.orcidTaslimi, Parham/0000-0002-3171-0633
dc.identifier.orcid, ibrahim/0000-0002-5757-9899
dc.identifier.orcidPoustforoosh, Alireza/0000-0001-7780-5008
dc.identifier.orcidNaghiyev, Farid/0009-0003-9325-1756
dc.identifier.scopus2-s2.0-85137901381
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1002/slct.202202006
dc.identifier.urihttps://hdl.handle.net/11772/19816
dc.identifier.volume7
dc.identifier.wosWOS:000848257800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofChemistryselect
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectEnzyme Inhibition
dc.subjectIsatylidene Malononitrile
dc.subjectMolecular Docking
dc.subjectPyrimidine
dc.subjectPyran
dc.titleSynthesis and Biological Activity of Functionally Substituted Pyrimidine and Pyran Derivatives on the Basis of Isatylidene Malononitriles
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscoverydadfa319-65b8-4543-92b4-bea49e0139e9

Dosyalar